SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-13-332849
Filing Date
2013-08-13
Accepted
2013-08-13 17:00:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 d583810d424b3.htm 424B3 292482
  Complete submission text file 0001193125-13-332849.txt   293657
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-182447 | Film No.: 131033772
SIC: 2834 Pharmaceutical Preparations